In a previous analysis of HNSCC, there was no observable effect of p16, MGMT, DAPK, or E-cadherin on prognosis for patients with laryngeal and hypopharyngeal cancer [8]. The gene discussed is DAPK1; the disease is head and neck squamous cell carcinoma.